SevenBridge Financial Group’s Novo Nordisk NVO Stock Holding History

SevenBridge Financial Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,000	Closed	-$26K	–	432
2019 Q2	$26K	Hold	1,000	–	–	0.01%	361
2019 Q1	$26K	Hold	1,000	–	–	0.01%	312
2018 Q4	$23K	Hold	1,000	–	–	0.01%	282
2018 Q3	$24K	Hold	1,000	–	–	0.01%	322
2018 Q2	$23K	Hold	1,000	–	–	0.01%	329
2018 Q1	$25K	Hold	1,000	–	–	0.01%	326
2017 Q4	$27K	Hold	1,000	–	–	0.01%	335
2017 Q3	$24K	Hold	1,000	–	–	0.01%	351
2017 Q2	$21K	Hold	1,000	–	–	0.01%	376
2017 Q1	$18K	Hold	1,000	–	–	0.01%	385
2016 Q4	$20K	Hold	1,000	–	–	0.01%	370
2016 Q3	$20K	Hold	1,000	–	–	0.01%	366
2016 Q2	$27K	Buy	+1,000	New	+$27.4K	0.02%	367

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SevenBridge Financial Group's NVO Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Novo Nordisk (NVO) in Q3 2019, closing a stake of 1,000 shares — an estimated $26K sold.

SevenBridge Financial Group first reported a position in NVO in Q2 2016 and held it in 13 quarters. The position peaked at $27K in Q4 2017. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

SevenBridge Financial Group reported no remaining Novo Nordisk position as of Q3 2019 after selling out during the quarter.
SevenBridge Financial Group sold 1,000 Novo Nordisk shares in Q3 2019, an estimated $26K.
SevenBridge Financial Group first reported a position in Novo Nordisk in Q2 2016 and held it in 13 quarters.
SevenBridge Financial Group's Novo Nordisk position peaked at $27K in Q4 2017.
564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.